Tonix Pharmaceuticals Holding Corp. (TNXP)
12.43
-0.12
(-0.96%)
USD |
NASDAQ |
Aug 24, 16:00
12.43
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Debt to Equity Ratio : 0.0057 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0057 |
| March 31, 2026 | 0.0057 |
| December 31, 2025 | 0.0053 |
| September 30, 2025 | 0.0018 |
| June 30, 2025 | 0.0029 |
| March 31, 2025 | 0.0031 |
| December 31, 2024 | 0.0582 |
| September 30, 2024 | 0.1171 |
| June 30, 2024 | 0.2199 |
| March 31, 2024 | 0.0908 |
| December 31, 2023 | 0.093 |
| September 30, 2023 | 0.0095 |
| June 30, 2023 | 0.009 |
| March 31, 2023 | 0.0062 |
| December 31, 2022 | 0.0037 |
| September 30, 2022 | 0.0039 |
| June 30, 2022 | 0.0038 |
| March 31, 2022 | 0.0039 |
| December 31, 2021 | 0.0044 |
| September 30, 2021 | 0.0055 |
| June 30, 2021 | 0.0058 |
| March 31, 2021 | 0.0054 |
| December 31, 2020 | 0.015 |
| September 30, 2020 | 0.0193 |
| June 30, 2020 | 0.0082 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.009 |
| December 31, 2019 | 0.038 |
| September 30, 2019 | 0.0473 |
| June 30, 2019 | 0.0452 |
| March 31, 2019 | 0.0326 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.0066 |
| March 31, 2014 | 0.0058 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Exelixis, Inc. | 0.09 |
| Inovio Pharmaceuticals, Inc. | 1.831 |
| Heron Therapeutics, Inc. | 21.48 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 254.09M |
| Total Liabilities (Quarterly) | 31.81M |
| Shareholders Equity (Quarterly) | 222.28M |
| Current Ratio | 6.608 |
| Net Debt Paydown Yield | -0.07% |